| UniProt ID | CG050_HUMAN | |
|---|---|---|
| UniProt AC | Q9BRJ6 | |
| Protein Name | Uncharacterized protein C7orf50 | |
| Gene Name | C7orf50 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 194 | |
| Subcellular Localization | ||
| Protein Description | ||
| Protein Sequence | MAKQKRKVPEVTEKKNKKLKKASAEGPLLGPEAAPSGEGAGSKGEAVLRPGLDAEPELSPEEQRVLERKLKKERKKEERQRLREAGLVAQHPPARRSGAELALDYLCRWAQKHKNWRFQKTRQTWLLLHMYDSDKVPDEHFSTLLAYLEGLQGRARELTVQKAEALMRELDEEGSDPPLPGRAQRIRQVLQLLS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 | Acetylation | -----MAKQKRKVPE -----CCCCCCCCCH | 55.86 | 7304113 | |
| 14 | 2-Hydroxyisobutyrylation | KVPEVTEKKNKKLKK CCCHHHHHHCHHHHH | 52.89 | - | |
| 14 | Acetylation | KVPEVTEKKNKKLKK CCCHHHHHHCHHHHH | 52.89 | 25953088 | |
| 23 | Phosphorylation | NKKLKKASAEGPLLG CHHHHHHCCCCCCCC | 35.41 | 30266825 | |
| 36 | Phosphorylation | LGPEAAPSGEGAGSK CCCCCCCCCCCCCCC | 44.76 | 21815630 | |
| 42 | Phosphorylation | PSGEGAGSKGEAVLR CCCCCCCCCCCEEEC | 36.63 | 25850435 | |
| 43 | Acetylation | SGEGAGSKGEAVLRP CCCCCCCCCCEEECC | 60.91 | 26051181 | |
| 59 | Phosphorylation | LDAEPELSPEEQRVL CCCCCCCCHHHHHHH | 28.71 | 29255136 | |
| 97 | Phosphorylation | QHPPARRSGAELALD CCCCCHHCCHHHHHH | 36.48 | 25159151 | |
| 105 | Phosphorylation | GAELALDYLCRWAQK CHHHHHHHHHHHHHH | 14.46 | 22817900 | |
| 107 | Glutathionylation | ELALDYLCRWAQKHK HHHHHHHHHHHHHHC | 2.51 | 22555962 | |
| 162 | Acetylation | ARELTVQKAEALMRE HHHHHHHHHHHHHHH | 43.81 | 25953088 | |
| 175 | Phosphorylation | RELDEEGSDPPLPGR HHHHHCCCCCCCCHH | 50.66 | 19664994 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CG050_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CG050_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23; SER-59; SER-97 ANDSER-175, AND MASS SPECTROMETRY. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-59, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-175, AND MASSSPECTROMETRY. | |